NCT04640558

Brief Summary

This study aimed to investigate the relationship between latent MTrPs and gluteus medius muscle strength in a group of healthy adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

November 17, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 23, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2021

Completed
Last Updated

January 29, 2021

Status Verified

January 1, 2021

Enrollment Period

2 months

First QC Date

November 17, 2020

Last Update Submit

January 28, 2021

Conditions

Keywords

Trigger pointGluteus medius muscle

Outcome Measures

Primary Outcomes (1)

  • Gluteus medius muscle strength

    In the participant's side-lying position, the practitioner will be applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants will be asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements will be repeated three times, one minute apart, on the right and left sides. The mean of the measurements will be calculated and recorded

    One month

Study Arms (2)

Group 1. Latent Myofascial Trigger Point Group

24 participants who will be clinically diagnosed with unilateral latent myofascial trigger point in the dominant side gluteus medius muscle.

Device: Muscle strength measurement

Group 2. Non-Latent Myofascial Trigger Point Group

24 participants who don't have latent myofascial trigger point.

Device: Muscle strength measurement

Interventions

The bilateral gluteus medius muscle strength of each participant will be measured by the assessor (MB) blinded to the participants using the Lafayette manual muscle tester. (Lafayette Instrument Company, Lafayette IN, USA). In the participant's side-lying position, the practitioner applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants were asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements were repeated three times, one minute apart, on the right and left sides. The mean of the measurements was calculated and recorded

Group 1. Latent Myofascial Trigger Point GroupGroup 2. Non-Latent Myofascial Trigger Point Group

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

24 participants who are clinically diagnosed with unilateral latent MTrP in the dominant side gluteus medius muscle and 24 participants who don't have latent MTrP.

You may qualify if:

  • Patient age: 18-40 years.
  • Absence of musculoskeletal complaints related to the lumbar, sacroiliac, and hip area.
  • Absence of bilateral latent MTrP in the gluteus medius muscle.
  • Latent trigger point in the gluteus medius muscle on the dominant side with palpation.

You may not qualify if:

  • A history of medical treatment, physical therapy, injection therapy, or surgical treatment related to the lumbar, sacroiliac, and hip area.
  • History of trauma, or malignancy or being pregnant, or if the patient is in the lactation period.
  • Bilateral latent MTrP in the gluteus medius muscle.
  • Presence of latent MTrP on the non-dominant side.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biruni University Faculty of Medicine

Istanbul, 34100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Myofascial Pain SyndromesMuscle Weakness

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

November 17, 2020

First Posted

November 23, 2020

Study Start

November 17, 2020

Primary Completion

January 17, 2021

Study Completion

January 17, 2021

Last Updated

January 29, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations